Published in PLoS One on July 07, 2017
MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol (2011) 220.97
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol (2006) 7.93
Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology (2001) 4.28
Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein. J Virol (1990) 4.16
Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. Hepatology (1998) 4.14
Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet (2012) 4.07
A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol (1995) 3.35
"Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet (1994) 3.33
Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med (1999) 3.08
Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice. J Virol (1986) 2.94
Occult hepatitis B virus infection. J Hepatol (2006) 2.79
Control of cccDNA function in hepatitis B virus infection. J Hepatol (2009) 2.41
Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med (1990) 2.36
Lack of 'occult' hepatitis B virus infection in HIV-infected patients. AIDS (2002) 1.92
Occult hepatitis B virus infection and its clinical implications. J Viral Hepat (2002) 1.82
Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants. J Virol (2003) 1.79
Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma. Hepatology (2011) 1.74
Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. Proc Natl Acad Sci U S A (2009) 1.74
Prevalence and significance of occult hepatitis B in a liver transplant population with chronic hepatitis C. Liver Transpl (2008) 1.72
Genomic targets of the KRAB and SCAN domain-containing zinc finger protein 263. J Biol Chem (2009) 1.71
Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection. J Hepatol (2011) 1.70
Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study. Eur J Clin Microbiol Infect Dis (1998) 1.69
Occult HBV infection in cryptogenic liver cirrhosis in an area with high prevalence of HBV infection. Am J Gastroenterol (2002) 1.68
Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Gut (2005) 1.66
Occult hepatitis B virus infection of donor and recipient origin after liver transplantation despite nucleoside analogue prophylaxis. Liver Transpl (2010) 1.59
Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Gastroenterology (1997) 1.54
Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy. Virology (2002) 1.53
Occult HBV infection. Semin Immunopathol (2012) 1.37
Hepatitis B virus nucleocapsids formed by carboxy-terminally mutated core proteins contain spliced viral genomes but lack full-size DNA. J Virol (2004) 1.36
COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis. Clin Cancer Res (2008) 1.34
Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C. J Clin Microbiol (2002) 1.34
Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. Cancer (2006) 1.33
Molecular mechanisms underlying occult hepatitis B virus infection. Clin Microbiol Rev (2012) 1.30
A novel PCR technique using Alu-specific primers to identify unknown flanking sequences from the human genome. Genomics (1995) 1.30
Occult hepatitis B virus infection in a North American adult hemodialysis patient population. Hepatology (2004) 1.30
Effect of basal core promoter and pre-core mutations on hepatitis B virus replication. J Gen Virol (2008) 1.30
The laboratory diagnosis of hepatitis B virus. Can J Infect Dis Med Microbiol (2005) 1.29
Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors. J Hepatol (2012) 1.29
Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area. Hepatology (1993) 1.26
Hepatitis B virus infection in patients with idiopathic liver disease. Hepatology (1991) 1.23
The RasGrf family of mammalian guanine nucleotide exchange factors. Biochim Biophys Acta (2010) 1.22
Mechanism of viral persistence and resistance to nucleoside and nucleotide analogs in chronic hepatitis B virus infection. Antiviral Res (2004) 1.22
Hepatitis B virus DNA is frequently found in liver biopsy samples from hepatitis C virus-infected chronic hepatitis patients. J Med Virol (1998) 1.21
Trans-activation function of a 3' truncated X gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues. Proc Natl Acad Sci U S A (1990) 1.20
A novel hepatitis B virus genotyping system by using restriction fragment length polymorphism patterns of S gene amplicons. World J Gastroenterol (2004) 1.17
Subgenotype diversity of hepatitis B virus American genotype F in Amerindians from Venezuela and the general population of Colombia. J Med Virol (2008) 1.16
Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays. Hepatology (2000) 1.16
Occult hepatitis B virus infection in HBsAg negative patients undergoing liver transplantation: clinical significance. Liver Transpl (2004) 1.14
Occult HBV infection in hemodialysis setting is marked by presence of isolated antibodies to HBcAg and HCV. J Nephrol (2009) 1.10
Identification of hepatitis B virus indigenous to chimpanzees. Proc Natl Acad Sci U S A (2000) 1.08
Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection. J Viral Hepat (2004) 1.07
Molecular characterization of the Hepatitis B virus genotypes in Colombia: a Bayesian inference on the genotype F. Infect Genet Evol (2010) 1.07
Nucleoside/nucleotide analog inhibitors of hepatitis B virus polymerase: mechanism of action and resistance. Curr Opin Virol (2014) 1.04
Comprehensive genetic and epigenetic analysis of occult hepatitis B from liver tissue samples. Clin Infect Dis (2008) 1.04
Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women. Clin Infect Dis (2007) 1.01
Molecular characterization and functional analysis of occult hepatitis B virus infection in Chinese patients infected with genotype C. J Med Virol (2009) 1.01
Sodium taurocholate cotransporting polypeptide mediates woolly monkey hepatitis B virus infection of Tupaia hepatocytes. J Virol (2013) 1.01
Frequent occult hepatitis B virus infection in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis (2003) 0.99
Frequency of spontaneous mutations in an avian hepadnavirus infection. J Virol (2001) 0.98
Dysregulated surface gene expression from disrupted hepatitis B virus genomes. J Virol (1993) 0.97
Use of hepatitis B core antibody-positive donors for liver transplantation. Liver Transpl (2002) 0.96
Persistence of isolated antibodies to woodchuck hepatitis virus core antigen is indicative of occult infection. Hepatology (2004) 0.96
Molecular epidemiology and genetic diversity of hepatitis B virus genotype E in an isolated Afro-Colombian community. J Gen Virol (2009) 0.95
Hepatitis viruses and hematopoietic cell transplantation: A guide to patient and donor management. Blood (1999) 0.94
Studies of donors who transmit posttransfusion hepatitis. Transfusion (1980) 0.92
A1762T/G1764A mutations of hepatitis B virus, associated with the increased risk of hepatocellular carcinoma, reduce basal core promoter activities. Biochem Biophys Res Commun (2008) 0.92
Diagnostic strategy for occult hepatitis B virus infection. World J Gastroenterol (2011) 0.92
Integration of hepatitis B virus DNA into chromosomal DNA during acute hepatitis B. World J Gastroenterol (2005) 0.90
Universal primers for real-time amplification of DNA from all known Orthohepadnavirus species. J Clin Virol (2003) 0.89
Risk of transmission of hepatitis B virus from anti-HBC positive cadaveric organ donors: a collaborative study. Transplant Proc (2005) 0.89
Antiviral therapies: focus on hepatitis B reverse transcriptase. Int J Biochem Cell Biol (2012) 0.89
Duck hepatitis B virus polymerase gene mutants associated with resistance to lamivudine have a decreased replication capacity in vitro and in vivo. J Hepatol (2001) 0.89
Occult infection related hepatitis B surface antigen variants showing lowered secretion capacity. World J Gastroenterol (2015) 0.87
Occult HBV infection among Egyptian hepatocellular carcinoma patients. Virol J (2011) 0.86
Hepatitis B virus: from diagnosis to treatment. Pathol Biol (Paris) (2010) 0.86
Prevalence and profile of mutations associated with lamivudine therapy in Indian patients with chronic hepatitis B in the surface and polymerase genes of hepatitis B virus. J Med Virol (2002) 0.86
Hepatitis B virus and hepatitis C virus co-infection: additive players in chronic liver disease? Ann Hepatol (2005) 0.86
Etiology and Viral Genotype in Patients with End-Stage Liver Diseases admitted to a Hepatology Unit in Colombia. Hepat Res Treat (2011) 0.84
Mechanism of HBV genome variability and replication of HBV mutants. J Clin Virol (2005) 0.84
Prevalence, virology and antiviral drugs susceptibility of hepatitis B virus rtN238H polymerase mutation from 1865 Chinese patients with chronic hepatitis B. Antiviral Res (2011) 0.84
Differential microbial clearance and immunoresponse of Balb/c (Nramp1 susceptible) and DBA2 (Nramp1 resistant) mice intracerebrally infected with Mycobacterium bovis BCG (BCG). FEMS Immunol Med Microbiol (2002) 0.84
rtL180M mutation of hepatitis B virus is closely associated with frequent virological resistance to adefovir dipivoxil therapy. J Gastroenterol Hepatol (2012) 0.84
Low occurrence of occult hepatitis B virus infection and high frequency of hepatitis C virus genotype 3 in hepatocellular carcinoma in Brazil. Braz J Med Biol Res (2007) 0.84
Envelope proteins derived from naturally integrated hepatitis B virus DNA support assembly and release of infectious hepatitis delta virus particles. J Virol (2014) 0.83
Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients. Antivir Ther (2009) 0.83
Transmission of serologically silent hepatitis B virus along with hepatitis C virus in two cases of posttransfusion hepatitis. Transfusion (1992) 0.82
TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia. Carcinogenesis (2012) 0.82
Genetic variation of hepatitis B virus and its significance for pathogenesis. World J Gastroenterol (2016) 0.82
Occult hepatitis B virus infection with positive hepatitis B e antigen. Clin Chim Acta (2014) 0.81
Renal grafts from anti-hepatitis B core-positive donors: a quantitative review of the literature. Transpl Infect Dis (2012) 0.80
Hepatitis B virus genotype A2 harbours an L217R polymorphism which may account for a lower response to adefovir. J Antimicrob Chemother (2008) 0.79
Role of occult hepatitis B virus infection in chronic hepatitis C. World J Gastroenterol (2015) 0.79
Occult hepatitis B virus infection in liver transplant recipients with recurrent hepatitis C: relationship with donor age and fibrosis progression. Clin Transplant (2009) 0.79
Association of preS/S Mutations with Occult Hepatitis B Virus (HBV) Infection in South Korea: Transmission Potential of Distinct Occult HBV Variants. Int J Mol Sci (2015) 0.79
TP53 Mutations and HBX Status Analysis in Hepatocellular Carcinomas from Iran: Evidence for Lack of Association between HBV Genotype D and TP53 R249S Mutations. Hepat Res Treat (2011) 0.78
Occult hepatitis B virus infection among blood donors in Colombia. Virol J (2014) 0.78
Molecular mechanisms underlying HBsAg negativity in occult HBV infection. Eur J Clin Microbiol Infect Dis (2015) 0.77